ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 2431 - 2445 of 5996 products
UCB's Rheumatoid Arthritis Treatment Approved for China
$5.00
Available
Accuray-CNNC JV Breaks Ground on China Manufacturing Center
$5.00
Available
Initial 25 IPOs on the Shanghai STAR Board Jump 140% Higher in First Session
$5.00
Available
Yisheng's New $60 Million Rabies Vaccine Facility Approved by NMPA
$5.00
Available
CStone Approved to Start China Bridging Trial of Leukemia Drug
$5.00
Available
Ascentage to Start US Trial of Treatment for Drug-Resistant Leukemia Treatment
$5.00
Available
Celltrion Forms JV with Nan Fung to Develop Three Biosimilars in China
$5.00
Available
Shanghai Fosun Partners In-Vitro Lung Cancer Diagnostic with VolitionRx
$5.00
Available
GenScript Completes Phase I of Nanjing Biologics CDMO R&D/Production Center
$5.00
Available
Chipscreen Poised to be One of the First IPOs on Shanghai's STAR Exchange
$5.00
Available
Chengdu New Radiomedicine Raises $14 Million; Will Develop BTG's TheraSphere
$5.00
Available
Abbisko Acquires China Rights to Anti-Immunosuppresive Drug from Boston's X4
$5.00
Available
Cipla Forms $30 Million China Respiratory Drug JV with Jiangsu Acebright
$5.00
Available
EdiGene, a Beijing CRISPR/Cas9 Editing Company, Sells Knockout Cell Line Library to Abcam
$5.00
Available
Suzhou's Alphamab Oncology Approved to IPO on Hong Kong Exchange
$5.00
Available